Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal Indonesian Journal of Hospital Administration INPHARNMED Journal (Indonesian Pharmacy and Natural Medicine Journal)
Eva Nurinda
Department of Pharmacy, Faculty of Health Sciences, Alma Ata University
Health Professions Medicine & Pharmacology Nursing Public Health

Published : 3 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 3 Documents
Search

 1 
OBAT INFUSI MEMPENGARUHI KEJADIAN FLEBITIS PADA PASIEN RAWAT INAP DI BANGSAL UMUM RSUD WONOSARI TAHUN 2017 Eva Nurinda
INPHARNMED Journal (Indonesian Pharmacy and Natural Medicine Journal) Vol 1, No 1 (2017)
Publisher : Alma Ata University Press

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (551.954 KB) | DOI: 10.21927/inpharnmed.v1i1.542

Abstract

AbstrakFlebitis menjadi salah satu indikator mutu pelayanan Rumah Sakit. Angka kejadian flebitis di RSUD Wonosari masih tinggi yaitu pada tahun 2016 terdapat 131 kejadian flebitis. Penelitian ini bertujuan untuk mengetahui hubungan penggunaan obat secara infusi dengan kejadian flebitis pada pasien rawat inap di bangsal umum RSUD Wonosari. Penelitian yang dilakukan merupakan penelitian kualitatif dengan rancangan cohort dengan sampel 80 pasien yang dihitung dengan rumus slovin dan diambil  dengan  tehnik  purposive  sampling.  Instrumen  penelitian  yang  digunakan berupa lembar observasi dan analisis dengan metode deskriptif. Berdasarkan data penelitian didapatkan hasil bahwa pasien yang mengalami flebitis yaitu 41 pasien (51,2%). Sebanyak 55,56% pasien yang mendapatkan antibiotik mengalami flebistis dan 52,68% bukan antibiotik mengalami flebitis. Kejadian flebitis yang terjadi dapat disebabkan oleh faktor-faktor selain pemakaian obat melalui infus.  Kata Kunci: terapi melalui infus, antibiotik, flebitis.  AbstractPhlebitis is one of the indicators of hospital service quality. The incidence of phlebitis in RSUD Wonosari is still high, in 2016 there are 131 incidence of phlebitis. This study aims to determine the relationship between drug use in infusion with the incidence of phlebitis in hospitalized patients in the general ward RSUD Wonosari. The research was a qualitatif study with a cohort design with a sample of 80 patients calculated by the slovin formula and taken with purposive sampling technique. The research instrument that used was in the form of observation sheet and analysis with descriptive method. Based on the research data showed that patients with phlebitis were 41 patients (51.2%). As many as 55.56% of patients taking antibiotics had flebitis and 52.68% of patients taking not antibiotics had phlebitis. Phlebitis that happened can be caused by other factors than intravenous drug usage. Keywords: drug use in infusion, antibiotics, phlebitis.
OBAT INFUSI MEMPENGARUHI KEJADIAN FLEBITIS PADA PASIEN RAWAT INAP DI BANGSAL UMUM RSUD WONOSARI TAHUN 2017 Eva Nurinda
INPHARNMED Journal (Indonesian Pharmacy and Natural Medicine Journal) Vol. 1 No. 1 (2017)
Publisher : Alma Ata University Press

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.21927/inpharnmed.v1i1.542

Abstract

AbstrakFlebitis menjadi salah satu indikator mutu pelayanan Rumah Sakit. Angka kejadian flebitis di RSUD Wonosari masih tinggi yaitu pada tahun 2016 terdapat 131 kejadian flebitis. Penelitian ini bertujuan untuk mengetahui hubungan penggunaan obat secara infusi dengan kejadian flebitis pada pasien rawat inap di bangsal umum RSUD Wonosari. Penelitian yang dilakukan merupakan penelitian kualitatif dengan rancangan cohort dengan sampel 80 pasien yang dihitung dengan rumus slovin dan diambil  dengan  tehnik  purposive  sampling.  Instrumen  penelitian  yang  digunakan berupa lembar observasi dan analisis dengan metode deskriptif. Berdasarkan data penelitian didapatkan hasil bahwa pasien yang mengalami flebitis yaitu 41 pasien (51,2%). Sebanyak 55,56% pasien yang mendapatkan antibiotik mengalami flebistis dan 52,68% bukan antibiotik mengalami flebitis. Kejadian flebitis yang terjadi dapat disebabkan oleh faktor-faktor selain pemakaian obat melalui infus.  Kata Kunci: terapi melalui infus, antibiotik, flebitis.  AbstractPhlebitis is one of the indicators of hospital service quality. The incidence of phlebitis in RSUD Wonosari is still high, in 2016 there are 131 incidence of phlebitis. This study aims to determine the relationship between drug use in infusion with the incidence of phlebitis in hospitalized patients in the general ward RSUD Wonosari. The research was a qualitatif study with a cohort design with a sample of 80 patients calculated by the slovin formula and taken with purposive sampling technique. The research instrument that used was in the form of observation sheet and analysis with descriptive method. Based on the research data showed that patients with phlebitis were 41 patients (51.2%). As many as 55.56% of patients taking antibiotics had flebitis and 52.68% of patients taking not antibiotics had phlebitis. Phlebitis that happened can be caused by other factors than intravenous drug usage. Keywords: drug use in infusion, antibiotics, phlebitis.
Analisis Efektivitas Biaya Pengobatan DM Nefropati di RSUD Panembahan Senopati Bantul Putri Sumiyati; Eva Nurinda; Sofyan Indrayana; Eliza Dwinta
Indonesian Journal of Hospital Administration Vol 8 No 1 (2025)
Publisher : Universitas Alma Ata

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.21927/ijhaa.2025.8(1).54-64

Abstract

Diabetes mellitus is a group of metabolic diseases characterized by increased blood glucose. Diabetes mellitus can cause various chronic complications, one of which is diabetic nephropathy. The number of uses of treatment will cause differences in the effectiveness and cost of therapy.This study determined the cost effectiveness of nephropathy DM treatment in the Inpatient Ward of Panembahan Senopati Hospital, Bantul. This study was an analytic observational study with retrospective. Data collectional by looking at medical record and administrative data. As many as 63 respondent were inclusion criteria. The data obtained were analyzed using Microsoft Excel. Treatment effectiveness was measured based on patients who achieved ≤200 mg/dL Current Blood Sugar (GDS), while cost effectiveness was measured based on ACER and ICER values. The results showed that the effectiveness of drug B (non-insulin) was 88%, while drug A (insulin) was 85%. The average total cost of anti-diabetic drug B (non- insulin) is Rp. 839,563, and drug A (insulin) Rp. 1,163,473. drug group B (non- insulin) is more cost effective with an ACER value of Rp. 954,048, compared to drug A (insulin) of 1,368,791, in nephropathy DM patients at Panembahan Senopati Hospital, Bantul. The conclusion of this study shows that drug therapy group B (non- insulin) can be used as a cheaper and more effective treatment option for nephropathy DM patients
Co-Authors Eliza Dwinta Putri Sumiyati Sofyan Indrayana